Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/hepatitis-c-virus-antibody-in-hepatocellular-carcinoma-in-taiwan-HnxTlXVQG9
References (23)
-
H. Alter (1989)
Chronic Consequences of Non-A, Non-B Hepatitis -
E. Tabor (1989)
Hepatocellular carcinoma: Possible etiologies in patients without serologic evidence of hepatitis B virus infectionJournal of Medical Virology, 27
-
B. Sepúlveda, A. Rivera, E. Rojas (1952)
[Primary carcinoma of the liver].Gaceta medica de Mexico, 82 2
-
J. Bruix, X. Calvet, Josep Costa, Miquel Ventura, M. Bruguera, R. Castillo, J. Barrera, G. Ercilla, J. Sánchez‐Tapias, M. Vall, C. Bru, J. Rodés (1989)
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSISThe Lancet, 334
-
M. Colombo, Q. Choo, E. Ninno, N. Dioguardi, G. Kuo, M. Donato, M. Tommasini, M. Houghton (1989)
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 334
-
Mackenzie Dl, Gregory Dh, Vlahcevid Zr (1975)
Advances in viral hepatitis.Virginia medical monthly, 102 2
-
K. Uchiumi, M. Omata, K. Okuda (1987)
A follow-up study on the prognosis of chronic hepatitis. Difference between type B and non-B.Kanzo, 28
-
G. Kuo, Q. Choo, H. Alter, G. Gitnick, A. Redeker, R. Purcell, T. Miyamura, J. Dienstag, M. Alter, C. Stevens (1989)
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitisScience, 244
-
K. Kiyosawa, Y. Akahane, A. Nagata, S. Furuta (1984)
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.The American journal of gastroenterology, 79 10
-
K. Okuda, I. Fujimoto, A. Hanai, Y. Urano (1987)
Changing incidence of hepatocellular carcinoma in Japan.Cancer research, 47 18
-
M. Tong, S. Sun, B. Schaeffer, N. Chang, K. Lo, R. Peters (1971)
Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.Annals of internal medicine, 75 5
-
Kaeble-Elliott Ra, J. Tudor, Williams Jt (1964)
ROYAL COLLEGE OF PHYSICIANS. THE NEW BUILDING.Lancet, 2 7367
-
T. Lin, W. Tsu, C. Chen (1986)
Mortality of hepatoma and cirrhosis of liver in Taiwan.British Journal of Cancer, 54
-
Lin Lin, Tsu Tsu, Chen Chen (1986)
Mortality of hepatoma and cirrhosis of liverBritish Journal of Cancer, 54
-
D. Galloway, J. McDougall (1983)
The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanismNature, 302
-
M. Sakamoto, Setsuo Hirohashi, Hitoshi Tsuda, Y. Ino, Yukio Shimosato, Susumu Yamasaki, Masatoshi Makuuchi, Hiroshi Hasegawa, Masaaki Terada, Yasuhiro Hosoda (1988)
Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.Cancer research, 48 24 Pt 1
-
(1990)
NANB hepatitis virus as the cause of HCC -
Ding‐Shinn Chen (1987)
Hepatitis B Virus Infection, Its Sequelae, and Prevention in Taiwan -
C. Berman (1958)
Primary carcinoma of the liver.Advances in cancer research, 5
-
M. Kew, M. Houghton, Q. Choo, G. Kuo (1990)
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinomaThe Lancet, 335
-
Q. Choo, G. Kuo, A. Weiner, L. Overby, D. Bradley, M. Houghton (1989)
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science, 244 4902
-
Shibreski Shibreski, Soga Soga, Homma Homma, Ichida Ichida (1981)
Hepatic cancer and non‐A, non‐B type hepatitisNippon Rinsko, 39
-
H. Popper, D. Shafritz, J. Hoofnagle (1987)
Relation of the hepatitis B virus carrier state to hepatocellular carcinomaHepatology, 7
- Publisher
- Wiley
- Copyright
- Copyright © 1991 Wiley‐Liss, Inc., A Wiley Company
- ISSN
- 0146-6615
- eISSN
- 1096-9071
- DOI
- 10.1002/jmv.1890340113
- Publisher site
- See Article on Publisher Site
Abstract
The prevalence of antibody to hepatitis C virus (anti‐HCV) was investigated in patients with hepatocellular carcinoma (HCC), and correlated with the clinical features. Anti‐HCV was detected in 129 histology or aspiration cytology proven HCC patients and 54 healthy controls. Anti‐HCV was examined by the HCV EIA (Abbott Laboratories). All healthy controls were anti‐HCV‐negative. Nineteen of 81 (23.5%) hepatitis B surface antigen (HBsAg)‐positive HCC patients were positive for anti‐HCV. Anti‐HCV was found among 60.4% (29/48) of HCC patients without detectable HBsAg. Forty‐eight of 129 (37.2%) HCC patients were positive for anti‐HCV. There was a significant difference in the prevalence of anti‐HCV between patients with HBsAg (23.5%) and those without HBsAg (60.4%, P = 0.0001). However, irrespective of the status of HBsAg, there was no statistical difference in sex, age, routine liver function tests, alpha‐fetoprotein concentration, or associated cirrhosis between patients with anti‐HCV and those without. The results imply that hepatitis C virus may play a role in the pathogenesis of HCC.
Journal
Journal of Medical Virology – Wiley
Published: May 1, 1991